비교리스트

 카트 문의
시장보고서
상품코드
1486832

세계의 난원공개존(PFO) 폐쇄 기기 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2030년)

Patent Foramen Ovale (PFO) Closure Devices - Market Insights, Competitive Landscape and Market Forecast-2030
발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

전 세계 난원공개존(PFO) 폐쇄 기기 시장 규모는 2024-2030년의 예측 기간 동안 연평균 5.46%의 성장률을 보일 것으로 예상됩니다. 난원공 개존증(PFO) 폐쇄 기기에 대한 수요는 주로 노인 인구 증가와 뇌경색 발병률 증가로 인해 강화되고 있습니다. 또한, 전 세계적으로 신제품 개발 및 출시로 이어지는 기술 발전이 증가하고 있는 것도 2024-2030년의 예측 기간 동안 시장 성장에 기여하는 주요 요인으로 작용하고 있습니다.

난원공개존(PFO) 폐쇄 기기 시장 역학

세계보건기구(WHO)가 2022년 발표한 자료에 따르면, 2030년까지 전 세계 인구 6명 중 1명이 60세 이상 노인이 될 것이라고 합니다. 또한 이 자료에 따르면 60세 이상 인구는 2020년 10억 명에서 2050년까지 14억 명으로 늘어날 것으로 예상했습니다.

유엔 인구부에 따르면, 독일의 65세 이상 인구는 2050년까지 41% 증가한 2,400만 명으로 전체 인구의 3분의 1에 육박할 것으로 예측됩니다. 나이가 들어감에 따라 심장은 정상적인 노화 과정의 일환으로 다양한 구조적/기능적 변화를 겪습니다. 이러한 변화는 심혈관계에 영향을 미치며, 심방세동(PFO)의 지속 및 발병에 영향을 미칠 수 있습니다.

따라서 노령인구 증가는 난원공개존(PFO) 폐쇄 기기 시장의 성장에 긍정적인 영향을 미칠 것으로 예상됩니다.

미국뇌졸중협회(American Stroke Association)(2021)의 데이터에 따르면 허혈성 뇌졸중 환자 약 3명 중 1명(35%)은 은폐성 뇌졸중으로 분류됩니다. 또한 원인 불명의 뇌졸중의 절반은 색전성 뇌졸중입니다. 이처럼 뇌졸중 발병률이 증가함에 따라 뇌졸중 재발을 예방해야 할 필요성이 대두되고 있으며, 이는 난원공 개존증(PFO) 폐쇄장치 시장의 성장을 견인하고 있습니다.

그러나 합병증 및 장기적인 기기 안전성에 대한 우려, 난원공개존(PFO) 폐쇄 기기 및 수술과 관련된 높은 비용 등이 난원공개존(PFO) 폐쇄 기기 시장의 성장을 저해할 수 있습니다.

난원공개존(PFO) 폐쇄 기기 시장 부문 분석

난원공개존(PFO) 폐쇄 기기 시장의 제품 유형 부문에서 Amplatzer PFO 오클루더 카테고리는 2023년 난원공개존(PFO) 폐쇄 기기 시장에서 큰 수익 점유율을 차지할 것으로 추정됩니다. 이는 Amplatzer PFO 폐쇄 기기가 제공하는 다양한 이점에 기인합니다. Amplatzer PFO 폐쇄술이 제공하는 주요 이점 중 하나는 Amplatzer PFO 폐쇄술의 삽입이 일반적으로 경피적 카테터 폐쇄술과 같은 최소침습적 수술을 통해 이루어지기 때문에 PFO 폐쇄술이 제공하는 주요 이점 중 하나입니다. 삽입이 가능하다는 점입니다. 이 접근법은 개심술의 필요성을 피하고 회복 시간을 단축하고 수술 후 합병증을 줄일 수 있습니다. 또한, 이 장치는 PFO를 효과적으로 폐쇄하고 심실 간 혈전 및 기타 물질의 통과를 방지하도록 설계되어 뇌경색의 잠재적 원인인 기형적 색전증의 위험을 줄입니다. 따라서 Amplatzer PFO occluder가 제공하는 다양한 이점이 이 부문의 성장에 기여할 것으로 예상됩니다.

또한, 이 부문 수요가 증가함에 따라 시장 기업들은 다양한 신제품을 시장에 출시하고 있습니다. 예를 들어, 2022년 9월 Abbott는 난원공개존(PFO) 환자 치료를 위해 Amplatzer(TM) Talisman(TM) PFO Occlusion System을 유럽 시장에 출시하였습니다.

따라서, 위의 요인으로 인해 Amplatzer PFO 폐쇄기는 큰 성장을 기록할 것으로 예상되며, 이로 인해 예측 기간 동안 전체 난소 기공 폐쇄(PFO) 장비 시장의 성장을 가속할 것으로 예상됩니다.

북미가 전체 난자공개존(PFO) 폐쇄 기기 시장을 독점할 것으로 전망

북미는 2023년 난원공 개존증(PFO) 폐쇄 기기 시장에서 전체 지역 중 가장 높은 점유율을 차지할 것으로 예측됩니다. 이는 이 지역의 뇌졸중 발병률이 증가하고 있기 때문입니다. 또한, 기술 발전, 주요 기업의 존재, 노령 인구 증가, 제품 개발, 출시 및 승인 측면에서 높은 잠재력이 북미 PFO 폐쇄 기기 시장의 성장을 가속하는 요인으로 작용하고 있습니다.

이 보고서는 세계의 난공폐쇄장치(PFO) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 촉진요인 및 과제, 기업 및 제품 프로파일 등의 정보를 전해드립니다.

목차

제1장 난원공개존(PFO) 폐쇄 기기 시장 보고서 서론

제2장 난원공개존(PFO) 폐쇄 기기 시장 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 난원공개존(PFO) 폐쇄 기기 시장의 주요 요인 분석

  • 난원공개존(PFO) 폐쇄 기기 시장 성장 촉진요인 요인
  • 난원공개존(PFO) 폐쇄 기기 시장 성장 억제요인과 과제
  • 난원공개존(PFO) 폐쇄 기기 시장 기회

제6장 난원공개존(PFO) 폐쇄 기기 시장 : Porter의 Five Forces 분석

제7장 난원공개존(PFO) 폐쇄 기기 시장 동향

  • 제품 유형별
    • Amplatzer PFO Occluder
    • CardioForm Septal Occluder
    • 기타
  • 최종사용자별
    • 병원
    • 외래수술센터(ASC)
  • 지역
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 난원공개존(PFO) 폐쇄 기기 시장 기업과 제품 개요

  • Abbott
  • W. L. Gore & Associates, Inc.
  • Occlutech Holding AG
  • SMT
  • Cardia Inc.
  • Lepu Medical Technology(Beijing) Co., Ltd.
  • Lifetech Scientific
  • AGA Medical Corporation
  • pfm medical ag
  • Starway Medical Technology Inc.

제9장 KOL(Key Opinion Leader)의 견해

제10장 프로젝트 접근

제11장 DelveInsight에 대해

제12장 면책사항 및 문의

LSH 24.06.10

Patent Foramen Ovale Closure Device Market By Product Type (Amplatzer Pfo Occluder, Cardioform Septal Occluder, And Others), End-User (Hospitals And Ambulatory Surgical Centers), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing incidence of cryptogenic stroke and increasing technological advancement leading to new product development

The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030. The demand for Patent Foramen Ovale Closure device is primarily being bolstered by the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development and launches across the globe, is another major factor that is contributing to the growth of the Patent Foramen Ovale Closure market during the forecast period from 2024-2030.

Patent Foramen Ovale Closure Device Market Dynamics:

As per the data provided by the World Health Organization 2022, by the year 2030, 1 in 6 people in the world will be aged 60 years or over. Further, according to the same source the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion and by 2050.

According to the UN Population Division, Germany's population aged 65 and older is projected to grow by 41 percent to 24 million by 2050, accounting for nearly one-third of the total population. As the age increases the heart undergoes various structural and functional changes as a part of the normal aging process. These changes can affect the cardiovascular system, potentially contributing to the persistence or development of a Patent Foramen Ovale.

Therefore, the rise in the geriatric population will positively influence the growth of the Patent Foramen Ovale (PFO) Closure Devices market.

According to the data provided by the American Stroke Association 2021, around one in three which accounts for (35%) ischemic strokes are classified as cryptogenic. Additionally, half of the cryptogenic strokes are embolic strokes, which have an unknown origin. Thus, the rising incidence of cryptogenic strokes will create a need for the prevention of recurrent cryptogenic strokes thus eventually boosting the growth of the Patent Foramen Ovale Closure Device market.

However, the complications and concerns associated with the long-term safety of the device and the high cost associated with the Patent Foreman Ovale Closure Devices and procedures are some of the key constraints that may limit the growth of the Patent Foramen Ovale Closure Device market.

Patent Foramen Ovale Closure Device Market Segment Analysis:

Patent Foramen Ovale Closure Device Market by product type (Amplatzer PFO Occluder, Cardioform Septal Occluder, and Others), End-users (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the Patent Foramen Ovale Closure Device market, the Amplatzer PFO Occluder category is estimated to amass a significant revenue share in the Patent Foramen Ovale Closure Device Market in 2023. This can be attributed to the various advantages provided by Amplatzer PFO Occluder devices. The device is used for the treatment of certain medical conditions associated with PFO, such as cryptogenic strokes and recurrent migraines. One of the major advantages provided by Amplatzer PFO Occluder devices is that the insertion of the Amplatzer PFO Occluder is typically performed using a minimally invasive procedure, such as transcatheter closure. This approach avoids the need for open-heart surgery, leading to shorter recovery times and reduced postoperative complications. Additionally, the device is designed to effectively close the PFO, preventing the passage of blood clots or other materials between the heart chambers, thus reducing the risk of paradoxical embolism, which is a potential cause of cryptogenic strokes. Therefore, the various advantages provided by the Amplatzer PFO Occluder device is expected to contribute to the growth of the segment.

Furthermore, as the demand for this segment grows, various novel products are launched by market players in the market. For example, in September 2022, Abbott launched its Amplatzer(TM) Talisman(TM) PFO Occlusion System in the European market for the treatment of patients suffering from patent foramen ovale (PFO).

Therefore, owing to the above-mentioned factors, the Amplatzer PFO Occluder is expected to register significant growth, thereby driving the growth of the overall Patent Foramen Ovale Closure Device market during the forecast period.

North America Is Expected To Dominate The Overall Patent Foramen Ovale Closure Device Market:

North America is expected to account for the highest proportion of the Patent Foramen Ovale Closure Device Market in 2023, out of all regions. This is due to the increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, the presence of major players, increasing geriatric population, and a highly potent market in terms of product development, launches, and approvals are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.

According to the data provided by the American College of Cardiology 2019, it was estimated that cryptogenic strokes accounted for 15-40% of all strokes. Additionally, approximately 795,000 individuals suffer from cryptogenic strokes every year in the United States. Thus, the rising incidence of cryptogenic strokes will create a need for the treatment and management of Patent Foramen Ovale, thus resulting in the positive growth of the Patent Foramen Ovale Closure Device Market in the United States, which will eventually propel the Patent Foramen Ovale Closure Device market in North America.

Further, key players present in the region, such as, Abbott, W. L. Gore & Associates, Inc., and Occlutech Holding AG are currently driving a wide range of initiatives, such as enhancing market access and distribution, making investments in research and development and inking strategic collaborations and partnerships, which will further contribute for the growth of the Circadian Rhythm Sleep Disorders treatment market in North America.

Therefore, the factors mentioned above, are some of the important factors that are thereby responsible for driving the overall market for Patent Foramen Ovale Closure Devices in North America during the forecast period.

Patent Foramen Ovale Closure Device Market Key Players:

Some of the key market players operating in the Patent Foramen Ovale Closure Device market include Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.

Recent Developmental Activities In The Patent Foramen Ovale Closure Device Market:

  • In September 2021, the U.S. Food and Drug Administration (FDA) approved Abbott's Amplatzer(TM) Talisman(TM) PFO Occlusion System, which is used to treat patients suffering from Patent Foramen Ovale (PFO).
  • In March 2021, W.L. Gore & Associates, published the results of GORE REDUCE study long-term follow-up in The New England Journal of Medicine (NEJM), providing the benefits of patent foramen ovale closure devices. The extended follow-up data further illustrates the benefits of GORE CARDIOFORM Septal Occluder in long-term stroke prevention.

Key Takeaways From The Patent Foramen Ovale Closure Device Market Report Study

  • Market size analysis for current Patent Foramen Ovale Closure Device Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Patent Foramen Ovale Closure Device market.
  • Various opportunities available for the other competitors in the Patent Foramen Ovale Closure Device Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Patent Foramen Ovale Closure Device market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Patent Foramen Ovale Closure Device market growth in the coming future?

Target Audience Who Can Be Benefited From This Patent Foramen Ovale Closure Device Market Report Study

  • Patent Foramen Ovale Closure Device product providers
  • Research organizations and consulting companies
  • Patent Foramen Ovale Closure Devices-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Patent Foramen Ovale Closure Device
  • Various End-users who want to know more about the Patent Foramen Ovale Closure Device Market and the latest technological developments in the Patent Foramen Ovale Closure Device Market.

Frequently Asked Questions For The Patent Foramen Ovale Closure Device Market:

1. What is meant by Patent Foramen Ovale Closure Devices?

A Patent Foramen Ovale Closure Device is a medical device used to close a small hole called a foramen Ovale present between the upper two heart chambers (atria) in patients suffering from patent foramen Ovale.

2. What is the market for Patent Foramen Ovale Closure Devices?

The global Patent Foramen Ovale Closure Device Market is estimated to grow at a CAGR of 5.46% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Patent Foramen Ovale Closure Device market?

The Patent Foramen Ovale Closure Device Market is slated to witness prosperity owing to factors such as the rising geriatric population and increasing incidence of cryptogenic stroke. Additionally, increasing technological advancement leading to new product development across the globe, are some of the other factors resulting in appreciable revenue growth in the Patent Foramen Ovale Closure Device Market during the forecast period (2024-2030).

4. Who are the key players operating in the global Patent Foramen Ovale Closure Device market?

Some of the key market players operating in the Patent Foramen Ovale Closure Device Market Abbott, W. L. Gore & Associates, Inc., Occlutech Holding AG, SMT, and Cardia Inc., Lepu Medical Technology(Beijing)Co.,Ltd., Lifetech Scientific, AGA Medical Corporation, pfm medical ag, and Starway Medical Technology Inc.

5. Which region has the highest share in the global Patent Foramen Ovale Closure Device market?

North America is expected to dominate the overall Patent Foramen Ovale Closure Device Market during the forecast period, 2024 to 2030. This can be ascribed to the presence of developed and sophisticated healthcare infrastructure, rising aging population, and increasing incidence of cryptogenic strokes in the region. Additionally, rising technological advancements, presence of major players, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Patent Foramen Ovale Closure Device Market in North America.

Table of Contents

1. Patent Foramen Ovale Closure Device Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Patent Foramen Ovale Closure Device Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Patent Foramen Ovale Closure Device Market Key Factors Analysis

  • 5.1. Patent Foramen Ovale Closure Device Market Drivers
    • 5.1.1. Increasing Incidence of Cryptogenic Stroke
    • 5.1.2. Increasing technological advancement leading to new product development
    • 5.1.3. Rising geriatric population
  • 5.2. Patent Foramen Ovale Closure Device Market Restraints and Challenges
    • 5.2.1. Complications and concerns associated with the long-term safety of the device
    • 5.2.2. High cost associated with the Patent Foramen Ovale Closure Devices and procedures
  • 5.3. Patent Foramen Ovale Closure Device Market Opportunities
    • 5.3.1. Advancement in the material and design of Patent Foramen Ovale Closure Devices

6. Patent Foramen Ovale Closure Device Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Patent Foramen Ovale Closure Device Market Layout

  • 7.1. By Product Type
    • 7.1.1. Amplatzer PFO Occluder
    • 7.1.2. CardioForm Septal Occluder
    • 7.1.3. Others
  • 7.2. By End-user
    • 7.2.1. Hospitals
    • 7.2.2. Ambulatory Surgical Centers
  • 7.3. By Geography
    • 7.3.1. North America
      • 7.3.1.1. United States Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.1.2. Canada Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.1.3. Mexico Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
    • 7.3.2. Europe
      • 7.3.2.1. France Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.2.2. Germany Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.2.3. United Kingdom Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.2.4. Italy Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.2.5. Spain Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.2.6. Rest of Europe Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
    • 7.3.3. Asia-Pacific
      • 7.3.3.1. China Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.3.2. Japan Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.3.3. India Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.3.4. Australia Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.3.5. South Korea Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.3.6. Rest of Asia-Pacific Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
    • 7.3.4. Rest of the World (RoW)
      • 7.3.4.1. Middle East Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.4.2. Africa Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)
      • 7.3.4.3. South America Patent Foramen Ovale Closure Device Market Size in USD million (2021-2030)

8. Patent Foramen Ovale Closure Device Market Company and Product Profiles

  • 8.1. Abbott
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. W. L. Gore & Associates, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Occlutech Holding AG
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. SMT
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Cardia Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Lepu Medical Technology(Beijing)Co.,Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Lifetech Scientific
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. AGA Medical Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. pfm medical ag
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Starway Medical Technology Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy

9. KOL View

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제